Objective To review and qualitatively synthesize the evidence related to the economic
burden of COVID-19, including healthcare resource utilization and costs. Methods A …

Background We aimed to quantitatively summarise the health economic evaluation
evidence of prevention and control programs addressing COVID-19 globally. Methods We …

Introduction The COVID-19 pandemic is a global crisis impacting population health and the
economy. We describe a cost-effectiveness framework for evaluating acute treatments for …

Objectives As healthcare systems continue to respond to the COVID-19 pandemic, cost-
effectiveness evidence will be needed to identify which tests and treatments for COVID-19 …

Background The high rate of transmission and infection of coronavirus disease 2019
(COVID-19) is a public health emergency of major epidemiological concern. No definitive …

Objectives This study aims to conduct a systematic review of economic evaluations of
COVID-19 interventions and to examine whether and how these studies incorporate non …

Background This article investigates the hospital costs related to the management of COVID-
19 positive patients, requiring a hospitalization (from the positivity confirmation to discharge …

COVID-19 is a major public health problem, with still questionable specific cure. Favipiravir
is a COVID-19 antiviral that is potentially a therapy for COVID-19. This study aimed to …

Purpose We aimed to evaluate the cost effectiveness of Favipiravir treatment versus
standard of care (SC) in moderately to severely ill COVID-19 patients from the Saudi …

Purpose This study aimed to evaluate the cost-effectiveness of Azvudine for the treatment of
mild-to-moderate coronavirus disease 2019 in high-risk outpatients using real-world data …